SKWIERCZYNSKI RAYMOND D.,BUSCH TERRI F.,GUST-HEITING AMY L.,FRETLAND MARY T.,SCHOLZ MATTHEW T.
申请号：
PL37330302
公开号：
PL210514B1
申请日:
2002.11.27
申请国别(地区):
PL
年份:
2012
代理人:
摘要：
Pharmaceutical formulations comprising an immune response modifier (IRM) chosen from imidazoquinoline amines, imidazotetrahydroquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, thiazolo-quinolineamines, oxazolo-quinolinamines, thiazolo-pyridinamines, oxazolo-pyridinamines, imidazonaphthyridine amines, tetrahydroimidazonaphthyridine amines, and thiazolonaphthyridine amines； a fatty acid； and a hydrophobic, aprotic component miscible with the fatty acid are useful for the treatment of dermal associated conditions. Novel topical formulations are provided. In one embodiment, the topical formulations are advantageous for treatment of actinic keratosis, postsurgical scars, basal cell carcinoma, atopic dermatitis, and warts.
